+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Celecoxib alleviates oxaliplatin-induced hyperalgesia through inhibition of spinal ERK1/2 signaling

Celecoxib alleviates oxaliplatin-induced hyperalgesia through inhibition of spinal ERK1/2 signaling

Journal of Toxicologic Pathology 29(4): 253-259

Numerous pieces of evidence have revealed that oxaliplatin (OXA) evokes mechanical and cold hypersensitivity. However, the mechanism underlying these bothersome side effects needs to be further investigated. It is well known that cyclooxygenase-2 (COX-2) and extracellular signal-regulated kinases (ERK1/2) signaling play crucial roles in several pain states. Our previous data showed that Akt2 in the dorsal root ganglion (DRG) participated in the regulation of OXA-induced neuropathic pain. But it is still unclear whether spinal ERK1/2 signaling is involved in the regulation of OXA-induced hyperalgesia, and the linkage between COX-2 and ERK1/2 signaling in mediating OXA-induced hyperalgesia also remains unclear. In this research, we investigated the possible mechanism of celecoxib, a COX-2 inhibitor, in OXA-induced neuropathic pain. Our results show that single dose of OXA (12 mg/kg) significantly attenuated both the tail withdrawal latency (TWL) and mechanical withdrawal threshold (MWT) at days 4 after the OXA treatment. Administration of celecoxib (30 mg/kg/day) for 4 and 6 days inhibited the decrease in TWL and MWT, and each was significantly higher than that of the OXA+vehicle group and was equivalent to that of the vehicles group. OXA increased the expression of cyclooxygenase-2 (COX-2) mRNA and phosphorylated extracellular signal-regulated kinase1/2 (pERK1/2) protein in the lumbar 4-5 (L4-5) spinal cord dorsal horn neurons. Administration of celecoxib for 7 days suppressed the increase in expression of COX-2 and pERK1/2 induced by OXA. Our findings suggested that COX-2 and ERK1/2 signaling in spinal cord contributed to the OXA-induced neuropathic pain.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 057368271

Download citation: RISBibTeXText

PMID: 27821910

DOI: 10.1293/tox.2016-0032

Related references

Inhibition of spinal ERK1/2-c-JUN signaling pathway counteracts the development of low doses morphine-induced hyperalgesia. European Journal of Pharmacology 764: 271-277, 2015

The inhibition of spinal synaptic plasticity mediated by activation of AMP-activated protein kinase signaling alleviates the acute pain induced by oxaliplatin. Experimental Neurology 288: 85-93, 2017

Inhibition of Nerve Growth Factor Signaling Alleviates Repeated Dural Stimulation-induced Hyperalgesia in Rats. Neuroscience 398: 252-262, 2019

Selective prevention of mechanical hyperalgesia after incision by spinal ERK1/2 inhibition. European Journal of Pain 19(2): 225-235, 2015

Activation of cGMP-PKG signaling pathway mediates thiamine-induced inhibition of yhermal hyperalgesia in rats with spinal ganglion compression. FASEB Journal 17(4-5): Abstract No 439 8, 2003

IL-37 alleviates house dust mite-induced chronic allergic asthma by targeting TSLP through the NF-κB and ERK1/2 signaling pathways. Immunology and Cell Biology 97(4): 403-415, 2019

Transcutaneous electrical nerve stimulation attenuates CFA-induced hyperalgesia and inhibits spinal ERK1/2-COX-2 pathway activation in rats. Bmc Complementary and Alternative Medicine 13: 134, 2013

Inhibition of toll-like receptor 4 alleviates hyperalgesia induced by acute dural inflammation in experimental migraine. Molecular Pain 14: 1744806918754612, 2018

Inhibition of spinal constitutive NOS-2 by 1400W attenuates tissue injury and inflammation-induced hyperalgesia and spinal p38 activation. European Journal of Neuroscience 25(10): 2964-2972, 2007

Serotonergic signaling inhibits hyperalgesia induced by spinal cord damage. Brain Research 963(1-2): 312-320, 14 February, 2003

Role of ERK1/2 signaling during EGF-induced inhibition of palatal fusion. Developmental Biology 260(2): 2-21, 2003

Spinal inhibition is involved in mediating the formalin induced hyperalgesia in the rat. Society for Neuroscience Abstract Viewer & Itinerary Planner : Abstract No 656 2, 2002

Effects of spinal glycine inhibition on formalin-induced hyperalgesia in the rat. Anesthesiology 83(3A): A831, 1995

Inhibition of the Ras/Raf/ERK1/2 Signaling Pathway Restores Cultured Spinal Cord-Injured Neuronal Migration, Adhesion, and Dendritic Spine Development. Neurochemical Research 41(8): 2086-2096, 2016

Spinal phosphinositide 3-kinase-Akt-mammalian target of rapamycin signaling cascades in inflammation-induced hyperalgesia. Journal of Neuroscience 31(6): 2113-2124, 2011